Fig. 8
Schematic diagram. DNMT3B inhibits miR-451a transcription by methylation modification of the miR-451a promoter, thus activating EPHA2 and the following PI3K/AKT signaling, leading to BCa progression
Fig. 8 | BMC Cancer
Schematic diagram. DNMT3B inhibits miR-451a transcription by methylation modification of the miR-451a promoter, thus activating EPHA2 and the following PI3K/AKT signaling, leading to BCa progression